Affiliations: Department of Pediatrics, Section of Neonatology,
Children's Mercy Hospitals and Clinics, University of Missouri at Kansas City,
2401 Gillham Road, Kansas City, Missouri, MO 64108, USA. Tel.: +1 816 234
3592; Fax: +1 816 234 3596; E-mail: [email protected]; [email protected]
Abstract: Humidified high flow nasal cannula (HHFNC) has been suggested as an
alternative form of respiratory support for preterm infants with apnea,
respiratory distress syndrome or chronic lung disease, they appear to be easy
to apply and care for. Although, HHFNC may provide positive end-expiratory
pressure (PEEP), limited evidence is available to support the specific role,
efficacy, and safety of HHFNC in newborns. The evidence suggests that HHFNC
provides inconsistent and relatively unpredictable positive airway pressure,
but may be effective in the treatment of some neonatal respiratory conditions
while being more user-friendly for caregivers than conventional nCPAP. Caution
should be exercised in the use of HHFNC in neonates until further evidence is
available to clearly delineate its role and support its safety and efficacy.
The current controversy and the available data regarding the use of HHFNC in
providing noninvasive respiratory support in newborn infants are reviewed and
presented herein.